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The nuclear hormone receptor DAX-1 (dosage-sensitive sex reversal, adrenal 
hypoplasia critical region, on chromosome X, gene 1) is associated with the 
development and progression of prostate cancer within human males. Previous 
studies on DAX-1 have suggested a repression of steroidogenesis, indicating an 
inverse correlation between DAX-1 and steroidogenic gene expressions. To further 
understand the role of DAX-1 in tumor growth and development, experimentation 
was performed on Androgen Receptor (AR) sensitive and insensitive prostate 
cancer cell lines. Analysis of the different gene expression patterns of prostate 
cancer cell lines (including a CRISPR DAX-1 negative  cell line) under separate 
treatment conditions, provides conclusive data regarding the link between DAX-1 
and AR. The utilization of the DAX-1 negative cell line has also permitted the 
opportunity to develop a better understanding of advanced stage prostate cancer 
by simulating its inability to express the DAX-1 gene. The collected data on the 
relationship between DAX-1 and AR may aid in further studies to identify 
additional targets for the treatment of prostate cancer. 
 
Prostate cancer is the second most  common type of cancer found in men. The 
mechanisms behind the growth and metastasis of prostate cancer is still not fully 
understood leaving us to rely on findings from other cancers.  Previous studies 
on breast cancer have revealed that Androgen Receptors (AR)  when activated 
can induce the expression of DAX-1 which then can repress the expression and 
activity of aromatase in the steroidogenesis pathway.  Additionally, the studies 
have indicated that high expression ofDAX-1 can promote cell apoptosis.  [1]   
Figure 2. PCR and qPCR analysis of gene expression within prostate cancer cell lines 
in response to increasing Mb dosage. A) DU145: an AR negative cell line B) PC3: an 
AR and DAX-1 negative cell line C) LnCap: prostate cancer line known to express both 
genes D) LCR1: a successful CRISPR DAX-1 gene knock out cell line 
Chromatin Immunoprecipitation (ChIP) 
Figure 3. Potential targets on the DAX-1 gene used for ChIP assay. Three target regions 
within the DAX-1 gene were selected based on prior studies in breast cancer.  
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Figure 1.: http://www.clontech.com/US/Products/Genome_Editing/CRISPR_Cas9/Resources/About_CRISPR_Cas9 
 
 
•The activation of androgen receptors with Metribolone, appears to promote the 
expression of the DAX-1 gene 
 
•Exposure to androgen agonists, leads to an elevated protein expression in DAX-
1-1 and DAX-1-2 which to act as transcription factors , down regulating the 
expression in DAX-1-C 
 
•Perform western blot analysis to determine protein synthesis patterns between 
the different prostate cancer lines 
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Figure 4. Chromatin Immunoprecipitation analysis of DAX-1 targets. A & B) 
significant increase in DNA expression resulted from treatment with Mb, indicating a 
linkage between DNA and protein. C) target marker downstream the promoter region  
A) B) C) 
In some circumstances such as prostatic hyperplasia, DAX-1 expression is  
reduced drastically. [2] To simulate this behavior CRISPR/Cas9, a new age gene 
editing  technique, was used to knock out the DAX-1 gene from LnCap cells to 
produce a new cell line known as LCR1. To assess the different cell lines, 
Metribilone (Mb), a nonaromatizable drug, was used to activate the Androgen 
Receptors (AR) in order to identify different responses with increasing dosage 
which the expectation of a change in DAX-1 expression. [3] 
Figure 1. CRISPR/Cas9  gene knockout sequence  
Diagram produced by  Takara Bio Company © 2017 
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